blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3625344

EP3625344 - CORE MASTER REGULATORS OF GLIOBLASTOMA STEM CELLS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  15.12.2023
Database last updated on 20.07.2024
FormerExamination is in progress
Status updated on  11.12.2020
FormerRequest for examination was made
Status updated on  21.02.2020
FormerThe international publication has been made
Status updated on  23.11.2018
Formerunknown
Status updated on  18.06.2018
Most recent event   Tooltip15.12.2023Application deemed to be withdrawnpublished on 17.01.2024  [2024/03]
Applicant(s)For all designated states
University of Florida Research Foundation, Inc.
223 Grinter Hall
P.O. Box 115500
Gainesville, FL 32611-5500 / US
[2020/13]
Inventor(s)01 / LE, Son, B.
1105 Fort Clarke Boulevard
Apt. 601
Gainesville, Florida 32606 / US
02 / TRAN, David
7969 SW 87 Terrace
Gainesville, Florida 32608-8771 / US
 [2020/13]
Representative(s)Zacco Sweden AB
P.O. Box 5581
Löjtnantsgatan 21
114 85 Stockholm / SE
[N/P]
Former [2020/13]Zacco Sweden AB
P.O. Box 5581
114 85 Stockholm / SE
Application number, filing date18729196.815.05.2018
[2020/13]
WO2018IB53365
Priority number, dateUS201762506413P15.05.2017         Original published format: US 201762506413 P
US201762586655P15.11.2017         Original published format: US 201762586655 P
[2020/13]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018211409
Date:22.11.2018
Language:EN
[2018/47]
Type: A1 Application with search report 
No.:EP3625344
Date:25.03.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 22.11.2018 takes the place of the publication of the European patent application.
[2020/13]
Search report(s)International search report - published on:EP22.11.2018
ClassificationIPC:C12N15/113, A61K38/00
[2020/13]
CPC:
C12N15/1135 (EP,US); A61K45/06 (EP,US); C12N2310/14 (EP,US);
C12N2310/531 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/13]
TitleGerman:HAUPTREGULATOREN VON GLIOBLASTOMSTAMMZELLEN[2020/13]
English:CORE MASTER REGULATORS OF GLIOBLASTOMA STEM CELLS[2020/13]
French:RÉGULATEURS MAÎTRES DE NOYAU DE CELLULES SOUCHES DE GLIOBLASTOME[2020/13]
Entry into regional phase13.11.2019National basic fee paid 
13.11.2019Designation fee(s) paid 
13.11.2019Examination fee paid 
Examination procedure13.11.2019Examination requested  [2020/13]
13.11.2019Date on which the examining division has become responsible
29.06.2020Amendment by applicant (claims and/or description)
10.12.2020Despatch of a communication from the examining division (Time limit: M04)
08.04.2021Reply to a communication from the examining division
06.09.2021Despatch of a communication from the examining division (Time limit: M04)
14.01.2022Reply to a communication from the examining division
09.02.2023Despatch of a communication from the examining division (Time limit: M06)
22.08.2023Application deemed to be withdrawn, date of legal effect  [2024/03]
12.09.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2024/03]
Fees paidRenewal fee
31.03.2020Renewal fee patent year 03
13.05.2021Renewal fee patent year 04
27.05.2022Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.05.202306   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO2004096826  (UNIV BOLOGNA [IT], et al) [X] 1,9-12,14-16,18,19,21,22,24-28 * page 5, line 8 - line 10; claim 12 *;
 [X]WO2005028675  (ONCOTHERAPY SCIENCE INC [JP], et al) [X] 1,8,14-16,18-22,24-27,29,33,35* claims 15, 16 *;
 [XAI]WO2013188813  (UNIV CALIFORNIA [US], et al) [X] 1,7,9-16,18,19,21,22,24-27,29 * paragraphs [0393] , [ 405] * [A] 30-32 [I] 17,23;
 [X]EP3118306  (UNIST (ULSAN NAT INST OF SCIENCE AND TECHNOLOGY) [KR]) [X] 2-6,15,40 * claim 1 *;
 [X]  - JOHANSSON TERESE A ET AL, "Identification of Achaete-scute complex-like 1 (ASCL1) target genes and evaluation of DKK1 and TPH1 expression in pancreatic endocrine tumours", BMC CANCER, BIOMED CENTRAL, LONDON, GB, (20090910), vol. 9, no. 1, doi:10.1186/1471-2407-9-321, ISSN 1471-2407, page 321, XP021057699 [X] 1,7,9-16,18-22,24-27,29,34,36-39 * figure 1; table 2 *

DOI:   http://dx.doi.org/10.1186/1471-2407-9-321
by applicantUS2007207170
    - NAKAMURA et al., Nucleic Acids Research, (20000000), vol. 28, page 292
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.